Related Experiment Videos
Tetracycline-induced pancreatitis
D P Nicolau1, D E Mengedoht, J J Kline
1Department of Hospital Pharmacy Practice.
The American Journal of Gastroenterology
|November 1, 1991
Summary
Tetracycline can cause acute pancreatitis, even without liver damage. This study presents two new cases, highlighting the need to consider this side effect in patients with pancreatitis and no liver abnormalities.
Area of Science:
- Gastroenterology
- Pharmacology
- Hepatology
Background:
- Tetracycline is a broad-spectrum antibiotic with known associations to acute pancreatitis.
- Previous cases linked tetracycline-induced pancreatitis to concurrent liver dysfunction, specifically fatty degeneration.
- Limited data exist on pancreatitis occurring independently of significant liver abnormalities.
Observation:
- This report details the third and fourth documented cases of acute pancreatitis following oral tetracycline administration.
- Crucially, both patients presented with acute pancreatitis but showed no evidence of liver abnormalities.
- These cases challenge the established link between tetracycline-induced pancreatitis and overt liver failure.
Findings:
- Oral tetracycline can precipitate acute pancreatitis in the absence of detectable liver dysfunction.
- The mechanism may involve factors beyond direct hepatotoxicity leading to fatty degeneration.
- This expands the clinical spectrum of adverse reactions to tetracycline therapy.
Implications:
- Clinicians should consider tetracycline as a potential cause of acute pancreatitis, even in patients without liver abnormalities.
- Further research is warranted to elucidate the specific mechanisms of tetracycline-induced pancreatitis independent of liver failure.
- This finding necessitates careful patient selection and monitoring during tetracycline treatment, particularly for pancreatitis symptoms.